Leronlimab Treatment Trial for Near Death COVID Pa
Post# of 148166
(Total Views: 830)
Posted On: 11/11/2020 4:22:37 PM
Leronlimab Treatment Trial for Near Death COVID Patients.
NOTHING ELSE MATERS TILL 390. 293 Patients is NOT ENOUGH.
The only business objective for CYDY right now is to 390 clinical trial patients. Doctors, Hospitals, FDA, BP's and the Political Situation will not accept anything but full and complete FDA accepted data as defensible proof from a small, wacky little Biotech.
FILL THE TRIAL. STOP TALKING ABOUT ANYTHING ELSE.
Someone asks
Q: "How's HIV going?"
A: " We need 130 more clinical trial patients for near death COVID treatment drug Leronlimab "
Q: "What is NASDQ listing Status?
A:" We need 130 more clinical trial patients for near death COVID treatment drug Leronlimab "
Q: What's the name of your dog?
A: " We need 130 more clinical trial patients for near death COVID treatment drug Leronlimab "
Urgent. Compelling. Direct. Focused. All hands on deck - battle stations. All eyes on the prize. All oars pulling the same directions.
ONE OBJECTIVE AT A TIME.
NOTHING ELSE MATERS TILL 390. 293 Patients is NOT ENOUGH.
The only business objective for CYDY right now is to 390 clinical trial patients. Doctors, Hospitals, FDA, BP's and the Political Situation will not accept anything but full and complete FDA accepted data as defensible proof from a small, wacky little Biotech.
FILL THE TRIAL. STOP TALKING ABOUT ANYTHING ELSE.
Someone asks
Q: "How's HIV going?"
A: " We need 130 more clinical trial patients for near death COVID treatment drug Leronlimab "
Q: "What is NASDQ listing Status?
A:" We need 130 more clinical trial patients for near death COVID treatment drug Leronlimab "
Q: What's the name of your dog?
A: " We need 130 more clinical trial patients for near death COVID treatment drug Leronlimab "
Urgent. Compelling. Direct. Focused. All hands on deck - battle stations. All eyes on the prize. All oars pulling the same directions.
ONE OBJECTIVE AT A TIME.
(6)
(2)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼